Pacira Biosciences, Inc. (PCRX)
22.64
-0.89
(-3.78%)
USD |
NASDAQ |
May 15, 16:00
22.62
-0.02
(-0.07%)
After-Hours: 20:00
Pacira Biosciences Total Assets (Quarterly) : 1.209B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 814.88M |
| Bristol Myers Squibb Co. | 86.48B |
| Assertio Holdings, Inc. | 211.30M |
| Johnson & Johnson | 200.89B |
| Eli Lilly & Co. | 116.58B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 554.64M |
| Shareholders Equity (Quarterly) | 653.89M |
| Debt to Equity Ratio | 0.6288 |
| Current Ratio | 4.734 |
| Net Debt Paydown Yield | 5.13% |